Parkhomenko Taisiya A, Doronin Vasilii B, Castellazzi Massimiliano, Padroni Marina, Pastore Michela, Buneva Valentina N, Granieri Enrico, Nevinsky Georgy A
Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Siberian Division, Novosibirsk, Russia.
Novosibirsk Medical University, Ministry of Public Health of Russian Federation, Novosibirsk, Russia.
PLoS One. 2014 Apr 15;9(4):e93001. doi: 10.1371/journal.pone.0093001. eCollection 2014.
It was found that high-affinity anti-DNA antibodies were one of the major components of the intrathecal IgG response in multiple sclerosis (MS) patients [Williamson et al., PNAS, 2001]. Recently we have shown that IgGs from the sera of MS patients are active in the hydrolysis of DNA. Here we have shown, for the first time, that average concentration of total proteins (132-fold), total IgGs (194-fold) and anti-DNA antibodies (200-fold) in the sera is significantly higher than that in the cerebrospinal fluid (CSF) of fifteen MS patients. The relative activities of total protein from sera and CSFs varied remarkably from patient to patient. It was surprising that the specific DNase activity of the total protein of CSF reparations were 198-fold higher than the serum ones. Electrophoretically and immunologically homogeneous IgGs were obtained by sequential affinity chromatography of the CSF proteins on protein G-Sepharose and FPLC gel filtration. We present first evidence showing that IgGs from CSF not only bind but efficiently hydrolyze DNA and that average specific DNase activity of homogeneous antibodies from CSF is unpredictably ∼49-fold higher than that from the sera of the same MS patients. Some possible reasons of these findings are discussed. We suggest that DNase IgGs of CSF may promote important neuropathologic mechanisms in this chronic inflammatory disorder and MS pathogenesis development.
研究发现,高亲和力抗DNA抗体是多发性硬化症(MS)患者鞘内IgG反应的主要成分之一[威廉姆森等人,《美国国家科学院院刊》,2001年]。最近我们发现,MS患者血清中的IgG在DNA水解中具有活性。在此我们首次表明,15例MS患者血清中总蛋白(132倍)、总IgG(194倍)和抗DNA抗体(200倍)的平均浓度显著高于脑脊液(CSF)中的浓度。血清和脑脊液中总蛋白的相对活性在不同患者之间差异显著。令人惊讶的是,脑脊液制剂中总蛋白的特异性DNase活性比血清中的高198倍。通过将脑脊液蛋白在蛋白G-琼脂糖凝胶上进行连续亲和层析和FPLC凝胶过滤,获得了电泳和免疫均一的IgG。我们首次提供证据表明,脑脊液中的IgG不仅能结合DNA,还能有效地水解DNA,并且脑脊液中均一抗体的平均特异性DNase活性比同一MS患者血清中的高约49倍,这一结果出人意料。我们讨论了这些发现的一些可能原因。我们认为,脑脊液中的DNase IgG可能在这种慢性炎症性疾病和MS发病机制发展中促进重要的神经病理机制。